Welcome to the Valentine’s Day edition of Dispensed, Business Insider’s weekly healthcare newsletter. Consider this my Valentine to you. I’ll try to resist making any health-related poems. Are you new to the newsletter? You can sign up here. While I’m sure you’re busy buying up treats for loved ones and ready to head into the three-day weekend, first here’s a breakdown of all the big stories that kept the team busy this week. Last week, I mentioned the layoffs happening at Ancestry, which came just a few weeks after 23andMe also made a big cut to its staff. I also mentioned I’ve been asking myself the big question of what comes next for the industry.Well, I decided to turn to industry experts and figure out if I could find an answer.
Hollis Johnson/Business Insider
The DNA testing industry is stuck in a rut. Here’s how 23andMe and Ancestry are plotting their next moves.Two of the biggest consumer genetics companies — 23andMe and Ancestry — have recently laid off workers, citing a slowdown in the market for their tests. Consumers aren’t flocking to send their spit into genetic testing companies in as high a numbers as the industry expected, an issue the industry has sounded the alarm on for the past six months. Industry experts aren’t expecting that market to ever come back, forcing the companies to adopt new strategies. Here’s where the companies are betting the industry coul
Read More From Publisher